Stamford Advocate – OxyContin maker Purdue Pharma accounted for about 3 percent of the prescription opioids produced in the U.S. between 2006 and 2012, according to newly released federal data — but the disclosure of the small market share is unlikely to tamp down the intense legal pressure from the state of Connecticut and hundreds of other plaintiffs.
Business Law
Purdue Pharma bypasses state drug monitoring
Lawsuit: Sackler Emails ‘Shocking and Offensive’ to Opioid Victims
CT Post – Connecticut Attorney General William Tong released Tuesday an unredacted version of the state’s lawsuit against OxyContin maker Purdue Pharma, revealing emails from 2001 that he said showed company co-owner and former CEO and President Richard Sackler’s “shocking and offensive” disregard for victims of the opioid crisis — an assertion contested by Sackler’s attorney.
Connecticut Turns Up Pressure on OxyContin Maker Purdue Pharma
British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.
Many sue OxyContin maker, but not its own city: Stamford
Opioids: Boston trial opens what could be year of reckoning for executives
Purdue Pharma to research non-opioid treatments
Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.
Read article